Buy or build: Strategies to meet demand for vaccine and viral vector production
In the mid-20th century, the successful development and large-scale production of vaccines for a range of life-threatening diseases completely revolutionised…
Accelerating Biopharmaceutical Innovation
In association with Cytiva
Biopharma 4.0: The real-world benefits of modern manufacturing
Despite the large amount of attention it’s been getting in recent years, automation is by no means new. Manufacturers of…
Latest News
View More
Viral vector manufacturing: design considerations to improve commercial success
Viral vector manufacturing: the key to the success of gene therapy Frost & Sullivan recently invited industry thought leaders working in the viral vector manufacturing…
A standard approach to drug development for accessing the globe
Standardization in business requires us to take a step back from the belief that our technology and processes are unique and require specialized tools or…
Developing a new biologic drug: regulatory challenges and considerations
The journey from research lab to market is a long one, and most drug candidates do not make it. For…
Implementing the ballroom concept for biomanufacturing: Lessons, reflections and considerations from experience
The ballroom concept was originally defined in the International Society of Pharmaceutical Engineers (ISPE) Baseline Guide: Volume 6 - Biopharmaceutical…
